📰 High Throughput Screening News
Page 11 - High Throughput Screening News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from High Throughput Screening. Real-time updates on events, politics, business and more.
May 28, 2021
E-Mail The drug diABZI -- which activates the bodys innate immune response -- was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses. "Few drugs have been identified as game-changers in blocking SARS-CoV-2 infection. This paper is th...
May 25, 2021
The European Patent Office Grants Cannabics Pharmaceuticals Patent for Companys Personalized Medicine Drug Discovery Technology USA - English Share this article Share this article TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the companys patent titled: "System and Method for High Throughput Screening of Cancer Cells" has bee...
May 12, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The Global Liquid Handling System Market is estimated to be USD 3.53 Bn in 2021 and is expected to reach USD 4.98 Bn by 2026, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving th...
May 3, 2021
Competitive multiplex binding assay can monitor SARS-CoV-2 immune responses using nanobodies Measuring the presence and performance of neutralizing antibodies is crucial in the fight against the coronavirus disease 2019 (COVID-19) pandemic. This allows us to glimpse how effective vaccines and antibody therapies are in conferring protective immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Researchers in Germany and the U.S. described 11 unique nanobodies (Nbs) ...
April 27, 2021
REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapys 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapys 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://...
April 13, 2021
During the process of SARS-CoV-2 infection, once the virus penetrates the host cell, two open reading frames, ORF1a and ORF1ab, are translated. ORF1ab is responsible for the production of 16 nonstructural proteins (nsp). Several viral proteases such as 3CLpro and PLpro (papain-like protease) produce 1-16 nsps. A new study has been published in bioRxiv* preprint server, which deals with identifying drugs that are effective as PLpro inhibitors.
April 9, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The Global Liquid Handling System Market is estimated to be USD 3.3 Bn in 2020 and is expected to reach USD 4.65 Bn by 2025, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving the...
March 3, 2021
E-Mail IMAGE: with one of the newly developed inhibitors in the active centre. The individual domains of the protein are shown in different colours, the inhibitor in pink. view more Credit: © V. Namasivayam/Pharmazeutisches Institut/Uni Bonn A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, ...
March 3, 2021
A research team of pharmacists at the University of Bonn has discovered two families of active substances that can block the replication of the SARS-CoV-2 coronavirus. The drug candidates are able to switch off the the key enzyme of the virus, the so-called main protease.
March 2, 2021
Biological activity-based modeling offers a new approach for drug discovery Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This action-based focus -- called biological activity-based modeling (BABM) -- forms the core of a new approach developed by the National Center for Advancing Translational Sciences (NCATS) researchers and others. NCATS is part o...